While the TC is a widely used tool for breast cancer risk prediction, its limitations in predicting breast cancer risk in carriers of non‐BRCA1/2 PVs highlight the need for continued research into more accurate risk prediction models. This evidence concerns the gene BRCA1 and breast cancer.